Cargando…
Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521540/ https://www.ncbi.nlm.nih.gov/pubmed/36186465 http://dx.doi.org/10.3389/fgene.2022.994181 |
| _version_ | 1784799862370336768 |
|---|---|
| author | Kaur, Mandeep Dlamini, Zodwa |
| author_facet | Kaur, Mandeep Dlamini, Zodwa |
| author_sort | Kaur, Mandeep |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9521540 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95215402022-09-30 Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects Kaur, Mandeep Dlamini, Zodwa Front Genet Genetics Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9521540/ /pubmed/36186465 http://dx.doi.org/10.3389/fgene.2022.994181 Text en Copyright © 2022 Kaur and Dlamini. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Genetics Kaur, Mandeep Dlamini, Zodwa Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects |
| title | Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects |
| title_full | Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects |
| title_fullStr | Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects |
| title_full_unstemmed | Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects |
| title_short | Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects |
| title_sort | editorial: cholesterol and cancer drug resistance: molecular, signaling, and therapeutic aspects |
| topic | Genetics |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521540/ https://www.ncbi.nlm.nih.gov/pubmed/36186465 http://dx.doi.org/10.3389/fgene.2022.994181 |
| work_keys_str_mv | AT kaurmandeep editorialcholesterolandcancerdrugresistancemolecularsignalingandtherapeuticaspects AT dlaminizodwa editorialcholesterolandcancerdrugresistancemolecularsignalingandtherapeuticaspects |